Studies have shown that LAC can reverse the decrease in NGF caused by pressure exposure in the central nervous system (97), and normalize the levels of GDNF and ARTN in the peripheral and central nervous systems (98), but there is still a lack of relevant research on the effect of LAC on VEGF in mental illness
Key Takeaway: If you are using GLP-1 medications and have a thyroid condition, it is sensible to monitor your thyroid function more frequently, especially during the first few months of treatment or after a significant weight change
BPC-157 (Body Protection Compound-157) This is probably the most hyped "research peptide" right now
How much weight can a transplant patient expect to lose on semaglutide
Most countries allow personal-use quantities of prescription injectable medications without restriction
While there are limited treatment options for liver fibrosis, a recent clinical trial showed in the explorative secondary endpoint that tirzepatide (TZP), a glucagon-like peptide-1 receptor (GLP1R) and glucose-dependent insulinotropic polypeptide receptor (GIPR) dual agonist that was approved for the treatment of type 2 diabetes in 2022 28 , reduces liver fibrosis in patients with metabolic dysfunction-associated steatohepatitis (MASH) 29